BHCM
CL icon

Brevan Howard Capital Management’s Colgate-Palmolive CL Stock Holding History

Brevan Howard Capital Management’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.02M Buy
11,909
+9,207
+341% +$821K 0.01% 891
2025
Q4 		$214K Buy
+2,702
New +$212K ﹤0.01% 1547
2025
Q3 		– Sell
-15,495
Closed -$1.41M – 1974
2025
Q2 		$1.41M Sell
15,495
-12,326
-44% -$1.13M 0.01% 905
2025
Q1 		$2.61M Buy
+27,821
New +$2.49M 0.03% 246
2024
Q2 		– Sell
-6,484
Closed -$584K – 1103
2024
Q1 		$584K Buy
+6,484
New +$549K 0.01% 411

Other funds holding CL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Brevan Howard Capital Management's CL Position: Q1 2026 in Review

Brevan Howard Capital Management increased its Colgate-Palmolive (CL) stake by 341% in Q1 2026, buying an estimated $821K and bringing the position to 11,909 shares worth $1.02M. The position accounts for 0.01% of the portfolio, ranked #891.

Brevan Howard Capital Management first reported a position in CL in Q1 2024 and has held it in 5 quarters since. The position peaked at $2.61M in Q1 2025. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Brevan Howard Capital Management held 11,909 shares of Colgate-Palmolive worth $1.02M as of Q1 2026.
  • Brevan Howard Capital Management bought 9,207 Colgate-Palmolive shares in Q1 2026, an estimated $821K.
  • Colgate-Palmolive made up 0.01% of Brevan Howard Capital Management's portfolio in Q1 2026, its #891 holding.
  • Brevan Howard Capital Management first reported a position in Colgate-Palmolive in Q1 2024 and has held it in 5 quarters since.
  • Brevan Howard Capital Management's Colgate-Palmolive position peaked at $2.61M in Q1 2025.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.